Found 1384 matching trials
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy PHASE2 Eighty to 90% of SCCHN (squamous cell carcinoma of head and neck) patients ...
Show More Location
Chang Gung Memorial Hospital
Learn More & Join Trial
Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma PHASE2 To evaluate whether the 2-year local failure-free survival (LRFFS) in Cohor...
Show More Location
Fudan Universtiy Shanghai Cancer Center
Learn More & Join Trial
Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer PHASE2 The current trial is evaluating the impact of deep regional hyperthermia on...
Show More Location
University Hospital Tübingen, Department of Radiation Oncology
Learn More & Join Trial
TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma PHASE3 The purpose of this study is to compare the survival and toxicity of TPC (T...
Show More Learn More & Join Trial
Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations PHASE3 Taste changes are common in cancer patients receiving concurrent chemoradia...
Show More Location
Dow University of Health Sciences
Learn More & Join Trial
Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma PHASE2 This is an open-label, parallel controlled, phase IIa exploratory study tha...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC PHASE3 The purpose of this study is to compare the efficacy and safety of sequenti...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer. PHASE1 The purpose of this study is to determine the maximum tolerated dose and sa...
Show More Learn More & Join Trial
A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma PHASE3 This is a phase 3, randomized, double-blind, placebo-controlled study to co...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer PHASE2 This study will enroll patients with limited-stage small cell lung cancer (...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial